.svg){kind=small}
Where to Buy
Müv / MUV is stocked at 45 licensed dispensaries across Arizona and Florida, 44 of them in Arizona, with the deepest coverage in Phoenix, Tucson, Chandler, Glendale, and Mesa. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Müv / MUV concentrated 92.73% of September 2026 sales in Topical, down 61.81% year over year and 24.86% month over month, while Concentrates held 7.27% share with a 16.23% month-over-month lift despite an 8.33% year-over-year dip. The brand’s average price fell 23.13% year over year to $14.63, with Topical priced at $15.07 and Concentrates at $10.71, and Topical ranked 7th in Arizona Topical. This mix and pricing pattern implies over-reliance on a contracting Topical base that is pulling overall sales down 60.11% year over year, while a small but growing Concentrates pocket is not yet large enough to offset Topical’s month-over-month drag.
With Topical share near 93% and a 7th-place category rank in Arizona, the brand’s positioning is anchored in a segment with shrinking volumes, forcing unit-led gains via lower prices that are not converting into share defense or rank improvement. The 16.23% month-over-month rise in Concentrates against a 24.86% Topical decline suggests a viable secondary lane for diversification, but at 7.27% share and an 8.33% year-over-year decline it remains too small to meaningfully rebalance risk, implying the brand should either consolidate around defensible Topical niches or accelerate SKU and channel expansion in Concentrates to reduce volatility.
Competitive Landscape
Mfcv / MUV sits at rank #7 in Arizona Topical for September 2026, down four spots YoY from #3, and two spots since June 2026 when it was #5; the brand’s arc contrasts with Drip Oils + Extracts holding #1 with a 49.7% YoY sales increase and Gramz rising from #7 to #2 alongside a 97.3% YoY sales gain, while iLava at #3 posted an 8.9% YoY sales decline yet still outranks Mfcv / MUV; despite a historical peak of #2 in October 2025, the current #7 rank amid competitor climbs and mixed declines (e.g., Tru Infusion at #5 with a 46.3% YoY drop) implies Mfcv / MUV has ceded share to faster-advancing peers and must reverse multi-quarter slippage to reenter the top five.
Notable Products
The steepest movement in September 2026 was the CBD/THC 1:1 Unscented Sports Gel (100mg CBD, 100mg THC) plunging 69.9% month over month and sitting at rank 8, while the CBD/THC 1:1 Transdermal Patch (10mg CBD, 10mg THC) fell 68.0% to rank 9. The top of the chart also contracted, with CBD/THC 1:1 Transdermal Patch Gen2 (10mg CBD, 10mg THC) at rank 1 down 28.0% and Hybrid Gen2 THC Transdermal Patch (20mg) at rank 2 down 30.3%, indicating pressure on the flagship patch formats. Six of the top ten are Topical SKUs, yet the CBD/THC 1:1 Pain Relief Cream (100mg CBD, 100mg THC) declined 54.9% at rank 7 while the CBD/THC 1:1 Soothing Sports Gel (100mg CBD, 100mg THC) was essentially flat at -0.3% at rank 3, suggesting demand is rotating within topicals rather than exiting the category. The mix points to Müv / MUV needing to rebalance away from legacy patch SKUs toward gels and lotions where retention is steadier, using targeted price or pack architecture rather than chasing volume with discounts.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
